(561) 802-3060 info@mri-news.com

This study is now closed to enrollment. To view currently enrolling studies please go to our currently enrolling studies page. For information on additional studies that will open in the future, please visit our upcoming studies page.

We are recruiting overweight and obese participants for a clinical research study investigating a product in capsule, Gelesis200. Qualied participants will: • be men or women 22 – 65 years of age • be generally healthy with the exception of being overweight (or obese) Study participants will receive all assessments, dietary counseling, and study products at no charge. You may also be reimbursed for your time and travel. If you would like to participate in a clinical research study testing the effect of Gelesis200, where you will receive dietary counseling for weight loss, we would like to hear from you. For more information, please call (561) 802-3060, ext. 8046, or complete the study information form on this page.
For more information, or to see if you qualify to participate in this study, please enter the following information*:
*We respect your privacy.  All information submitted in this form is transmitted over secure servers, and will be kept strictly confidential.  In response to your inquiry, your information will be added to our in-house database and you will be contacted by email and/or phone by a clinical study coordinator to discuss research opportunities available to you.
Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.